Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Sensitive bioluminescence imaging of fungal dissemination to the brain in mouse models of cryptococcosis.

Vanherp L, Ristani A, Poelmans J, Hillen A, Lagrou K, Janbon G, Brock M, Himmelreich U, Velde GV.

Dis Model Mech. 2019 May 17. pii: dmm.039123. doi: 10.1242/dmm.039123. [Epub ahead of print]

2.

Migrating a lab-developed MERS-CoV real-time PCR to 3 "Sample to Result" systems: experiences on optimization and validation.

Frans G, Beuselinck K, Peeters B, Van Ranst M, Saegeman V, Desmet S, Lagrou K.

Diagn Microbiol Infect Dis. 2019 Feb 10. pii: S0732-8893(18)30503-0. doi: 10.1016/j.diagmicrobio.2019.02.006. [Epub ahead of print]

PMID:
30929995
3.

Beta-d-Glucan for Diagnosing Pneumocystis Pneumonia: a Direct Comparison between the Wako β-Glucan Assay and the Fungitell Assay.

Mercier T, Guldentops E, Patteet S, Beuselinck K, Lagrou K, Maertens J.

J Clin Microbiol. 2019 May 24;57(6). pii: e00322-19. doi: 10.1128/JCM.00322-19. Print 2019 Jun.

PMID:
30918045
4.

Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.

Goemaere B, Lagrou K, Spriet I, Hendrickx M, Vandael E, Becker P, Catry B.

Mycoses. 2019 Jun;62(6):542-550. doi: 10.1111/myc.12912. Epub 2019 Apr 7.

PMID:
30887582
5.

Clinical and biochemical differences between hantavirus infection and leptospirosis: a retrospective analysis of a patient series in Belgium.

Bakelants E, Peetermans W, Lagrou K, Meersseman W.

Acta Clin Belg. 2019 Mar 18:1-8. doi: 10.1080/17843286.2019.1591654. [Epub ahead of print]

PMID:
30882283
6.

Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades.

Moens A, Verstockt B, Machiels K, Bossuyt P, Verdonck A, Lagrou K, van Assche G, Vermeire S, Ferrante M.

Eur J Gastroenterol Hepatol. 2019 Jun;31(6):668-673. doi: 10.1097/MEG.0000000000001394.

PMID:
30839436
7.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
8.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

9.

Comment on: Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies.

Lagrou K, Peetermans W, De Munter P.

J Antimicrob Chemother. 2019 Jan 23. doi: 10.1093/jac/dky570. [Epub ahead of print] No abstract available.

PMID:
30689906
10.

Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.

Mercier T, Schauwvlieghe A, de Kort E, Dunbar A, Reynders M, Guldentops E, Rijnders B, Verweij PE, Lagrou K, Maertens J.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01913-18. doi: 10.1128/JCM.01913-18. Print 2019 Apr.

PMID:
30651395
11.

Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients.

Hecke SV, Calcoen B, Lagrou K, Maertens J.

Future Microbiol. 2019 Feb;14:175-184. doi: 10.2217/fmb-2018-0250. Epub 2019 Jan 15.

PMID:
30644320
12.

Active neuroborreliosis or inflammation: are the diagnostic guidelines at stake?

De Cauwer H, Lagrou K, Coeckelbergh E, Bogaerts A, Leenders J, Vanneste D.

Acta Neurol Belg. 2019 Jun;119(2):207-214. doi: 10.1007/s13760-018-01067-2. Epub 2018 Dec 17.

PMID:
30556097
13.

Distribution of HCV genotypes in Belgium from 2008 to 2015.

Bouacida L, Suin V, Hutse V, Boudewijns M, Cartuyvels R, Debaisieux L, De Laere E, Hallin M, Hougardy N, Lagrou K, Oris E, Padalko E, Reynders M, Roussel G, Senterre JM, Stalpaert M, Ursi D, Vael C, Vaira D, Van Acker J, Verstrepen W, Van Gucht S, Kabamba B, Quoilin S, Muyldermans G.

PLoS One. 2018 Dec 5;13(12):e0207584. doi: 10.1371/journal.pone.0207584. eCollection 2018.

14.

First case of Candida auris infection in Belgium in a surgical patient from Kuwait.

Dewaele K, Frans J, Smismans A, Ho E, Tollens T, Lagrou K.

Acta Clin Belg. 2018 Dec 4:1-8. doi: 10.1080/17843286.2018.1555114. [Epub ahead of print]

PMID:
30514182
15.

Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary.

Wollants E, Smolders D, Naesens R, Bruynseels P, Lagrou K, Matthijnssens J, Van Ranst M.

Emerg Infect Dis. 2018 Dec;24(12):2380-2382. doi: 10.3201/eid2412.180494.

16.

Monitoring of Fluconazole and Caspofungin Activity against In Vivo Candida glabrata Biofilms by Bioluminescence Imaging.

Persyn A, Rogiers O, Brock M, Vande Velde G, Lamkanfi M, Jacobsen ID, Himmelreich U, Lagrou K, Van Dijck P, Kucharíková S.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01555-18. doi: 10.1128/AAC.01555-18. Print 2019 Feb.

PMID:
30420485
17.

Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations.

Padalko E, Lagrou K, Delforge ML, Jansens H, Ectors N, Pirnay JP, Klykens J, Sokal E, Muylle L, Libois A, Vanderkelen A, Verbeken G, Matthys C, Goossens D, Hanssens G, Baltes M, Beele H.

Cell Tissue Bank. 2018 Dec;19(4):835-836. doi: 10.1007/s10561-018-9728-8.

18.

Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP".

Delhaes L, Touati K, Faure-Cognet O, Cornet M, Botterel F, Dannaoui E, Morio F, Le Pape P, Grenouillet F, Favennec L, Le Gal S, Nevez G, Duhamel A, Borman A, Saegeman V, Lagrou K, Gomez E, Carro ML, Canton R, Campana S, Buzina W, Chen S, Meyer W, Roilides E, Simitsopoulou M, Manso E, Cariani L, Biffi A, Fiscarelli E, Ricciotti G, Pihet M, Bouchara JP.

J Cyst Fibros. 2019 Mar;18(2):212-220. doi: 10.1016/j.jcf.2018.10.001. Epub 2018 Oct 20. No abstract available.

PMID:
30348610
19.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations.

Padalko E, Lagrou K, Delforge ML, Jansens H, Ectors N, Pirnay JP, Klykens J, Sokal E, Muylle L, Libois A, Vanderkelen A, Verbeken G, Matthys C, Goossens D, Hanssens G, Baltes M, Beele H.

Cell Tissue Bank. 2018 Dec;19(4):681-695. doi: 10.1007/s10561-018-9721-2. Epub 2018 Aug 29. Erratum in: Cell Tissue Bank. 2018 Oct 26;:.

20.

Switch in childhood pneumococcal vaccine in Belgium.

Desmet S, Peetermans W, Lagrou K.

Lancet Infect Dis. 2018 Sep;18(9):945-946. doi: 10.1016/S1473-3099(18)30484-5. No abstract available.

PMID:
30152356
21.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
22.

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.

Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans DCJJ, Hoedemaekers A, Andrinopoulou ER, van den Berg CHSB, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J; Dutch-Belgian Mycosis study group.

Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.

PMID:
30076119
23.

Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.

Rogiers O, Holtappels M, Siala W, Lamkanfi M, Van Bambeke F, Lagrou K, Van Dijck P, Kucharíková S.

J Antimicrob Chemother. 2018 Oct 1;73(10):2806-2814. doi: 10.1093/jac/dky246.

PMID:
30010876
24.

Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?

Desmet S, Verhaegen J, Van Ranst M, Peetermans W, Lagrou K.

Lancet Infect Dis. 2018 Aug;18(8):830-831. doi: 10.1016/S1473-3099(18)30346-3. Epub 2018 Jul 11. No abstract available.

PMID:
30001857
25.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

26.

Genetic deficiency of NOD2 confers resistance to invasive aspergillosis.

Gresnigt MS, Cunha C, Jaeger M, Gonçalves SM, Malireddi RKS, Ammerdorffer A, Lubbers R, Oosting M, Rasid O, Jouvion G, Fitting C, Jong DJ, Lacerda JF, Campos A Jr, Melchers WJG, Lagrou K, Maertens J, Kanneganti TD, Carvalho A, Ibrahim-Granet O, van de Veerdonk FL.

Nat Commun. 2018 Jul 6;9(1):2636. doi: 10.1038/s41467-018-04912-3.

27.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2018 Aug 1;73(8):2274. doi: 10.1093/jac/dky218. No abstract available.

PMID:
29800383
28.

Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.

Goemaere B, Lagrou K, Spriet I, Hendrickx M, Becker P.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00591-18. doi: 10.1128/AAC.00591-18. Print 2018 Aug.

29.

A Multimodal Imaging Approach Enables In Vivo Assessment of Antifungal Treatment in a Mouse Model of Invasive Pulmonary Aspergillosis.

Poelmans J, Himmelreich U, Vanherp L, Zhai L, Hillen A, Holvoet B, Belderbos S, Brock M, Maertens J, Vande Velde G, Lagrou K.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00240-18. doi: 10.1128/AAC.00240-18. Print 2018 Jul.

30.

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.

Mercier T, Guldentops E, Lagrou K, Maertens J.

Front Microbiol. 2018 Apr 4;9:661. doi: 10.3389/fmicb.2018.00661. eCollection 2018. Review.

31.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

32.

A Framework for Understanding the Evasion of Host Immunity by Candida Biofilms.

Garcia-Perez JE, Mathé L, Humblet-Baron S, Braem A, Lagrou K, Van Dijck P, Liston A.

Front Immunol. 2018 Mar 16;9:538. doi: 10.3389/fimmu.2018.00538. eCollection 2018.

33.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

34.

Triazole resistance surveillance in Aspergillus fumigatus.

Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE; ISHAM/ECMM Aspergillus Resistance Surveillance working group.

Med Mycol. 2018 Apr 1;56(suppl_1):83-92. doi: 10.1093/mmy/myx144. Review.

PMID:
29538741
35.

Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice.

Vanherp L, Poelmans J, Hillen A, Govaerts K, Belderbos S, Buelens T, Lagrou K, Himmelreich U, Vande Velde G.

Sci Rep. 2018 Feb 14;8(1):3009. doi: 10.1038/s41598-018-20545-4.

36.

Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.

Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Mol Sci. 2018 Feb 9;19(2). pii: E523. doi: 10.3390/ijms19020523.

37.

EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.

Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Flörl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA.

Mycoses. 2018 May;61(5):326-330. doi: 10.1111/myc.12746. Epub 2018 Feb 20.

PMID:
29325218
38.

Antibiotic Resistance Plasmids Cointegrated into a Megaplasmid Harboring the blaOXA-427 Carbapenemase Gene.

Desmet S, Nepal S, van Dijl JM, Van Ranst M, Chlebowicz MA, Rossen JW, Van Houdt JKJ, Maes P, Lagrou K, Bathoorn E.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01448-17. doi: 10.1128/AAC.01448-17. Print 2018 Mar.

39.

Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients.

Gonçalves SM, Lagrou K, Rodrigues CS, Campos CF, Bernal-Martínez L, Rodrigues F, Silvestre R, Alcazar-Fuoli L, Maertens JA, Cunha C, Carvalho A.

Front Microbiol. 2017 Nov 29;8:2362. doi: 10.3389/fmicb.2017.02362. eCollection 2017.

40.

Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms.

Holtappels M, Swinnen E, De Groef L, Wuyts J, Moons L, Lagrou K, Van Dijck P, Kucharíková S.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01767-17. doi: 10.1128/AAC.01767-17. Print 2018 Jan.

41.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3325-3333. doi: 10.1093/jac/dkx319.

PMID:
29029256
42.

Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals.

Goemaere B, Becker P, Van Wijngaerden E, Maertens J, Spriet I, Hendrickx M, Lagrou K.

Mycoses. 2018 Feb;61(2):127-133. doi: 10.1111/myc.12714. Epub 2017 Nov 15.

PMID:
29024057
43.

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD.

Everaerts S, Lagrou K, Dubbeldam A, Lorent N, Vermeersch K, Van Hoeyveld E, Bossuyt X, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 31;12:2629-2638. doi: 10.2147/COPD.S141695. eCollection 2017.

44.

Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus.

Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB, Bragulat MR, Cabañes FJ, Carbia M, Chakrabarti A, Chaturvedi S, Chaturvedi V, Chen M, Chowdhary A, Colom MF, Cornely OA, Crous PW, Cuétara MS, Diaz MR, Espinel-Ingroff A, Fakhim H, Falk R, Fang W, Herkert PF, Ferrer Rodríguez C, Fraser JA, Gené J, Guarro J, Idnurm A, Illnait-Zaragozi MT, Khan Z, Khayhan K, Kolecka A, Kurtzman CP, Lagrou K, Liao W, Linares C, Meis JF, Nielsen K, Nyazika TK, Pan W, Pekmezovic M, Polacheck I, Posteraro B, de Queiroz Telles F Filho, Romeo O, Sánchez M, Sampaio A, Sanguinetti M, Sriburee P, Sugita T, Taj-Aldeen SJ, Takashima M, Taylor JW, Theelen B, Tomazin R, Verweij PE, Wahyuningsih R, Wang P, Boekhout T.

mSphere. 2017 Aug 30;2(4). pii: e00238-17. doi: 10.1128/mSphere.00238-17. eCollection 2017 Jul-Aug.

45.

Prevalence and seasonality of six respiratory viruses during five consecutive epidemic seasons in Belgium.

Ramaekers K, Keyaerts E, Rector A, Borremans A, Beuselinck K, Lagrou K, Van Ranst M.

J Clin Virol. 2017 Sep;94:72-78. doi: 10.1016/j.jcv.2017.07.011. Epub 2017 Jul 23.

PMID:
28772168
46.

Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study.

Alanio A, Gits-Muselli M, Guigue N, Desnos-Ollivier M, Calderon EJ, Di Cave D, Dupont D, Hamprecht A, Hauser PM, Helweg-Larsen J, Kicia M, Lagrou K, Lengerova M, Matos O, Melchers WJG, Morio F, Nevez G, Totet A, White LP, Bretagne S.

EBioMedicine. 2017 Aug;22:155-163. doi: 10.1016/j.ebiom.2017.06.027. Epub 2017 Jun 29.

47.

Added diagnostic value and impact on antimicrobial therapy of 16S rRNA PCR and amplicon sequencing on resected heart valves in infective endocarditis: a prospective cohort study.

Peeters B, Herijgers P, Beuselinck K, Verhaegen J, Peetermans WE, Herregods MC, Desmet S, Lagrou K.

Clin Microbiol Infect. 2017 Nov;23(11):888.e1-888.e5. doi: 10.1016/j.cmi.2017.06.008. Epub 2017 Jun 19.

48.

Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.

Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C.

Transplant Direct. 2017 Apr 18;3(5):e156. doi: 10.1097/TXD.0000000000000673. eCollection 2017 May.

49.

Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital.

Montesinos I, Argudín MA, Hites M, Ahajjam F, Dodémont M, Dagyaran C, Bakkali M, Etienne I, Jacobs F, Knoop C, Patteet S, Lagrou K.

J Clin Microbiol. 2017 Aug;55(8):2391-2399. doi: 10.1128/JCM.00520-17. Epub 2017 May 17.

50.

Improving outcome of fungal diseases - Guiding experts and patients towards excellence.

Cornely OA, Lass-Flörl C, Lagrou K, Arsic-Arsenijevic V, Hoenigl M.

Mycoses. 2017 Jul;60(7):420-425. doi: 10.1111/myc.12628. Epub 2017 May 12. Review.

Supplemental Content

Loading ...
Support Center